Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
Hagel S, Bach F, Brenner T, Bracht H, Brinkmann A, Annecke T, Hohn A, Weigand MA, Michels G, Kluge S, Nierhaus A, Jarczak D, König C, Weismann D, Frey O, Witzke D, Müller C, Bauer M, Kiehntopf M, Neugebauer S, Lehmann T, Roberts JA, Pletz MW; TARGET Trial Investigators. Hagel S, et al. Among authors: hohn a. Intensive Care Med. 2022 May;48(5):646-647. doi: 10.1007/s00134-022-06668-3. Intensive Care Med. 2022. PMID: 35303118 Free PMC article. No abstract available.
[Cancer patients in operative intensive care medicine].
Annecke T, Hohn A, Böll B, Kochanek M. Annecke T, et al. Among authors: hohn a. Anaesthesist. 2018 Feb;67(2):83-92. doi: 10.1007/s00101-018-0406-9. Anaesthesist. 2018. PMID: 29368008 Free PMC article. Review. German.
Prolonged antibiotic prophylaxis after thoracoabdominal esophagectomy does not reduce the risk of pneumonia in the first 30 days: a retrospective before-and-after analysis.
Hochreiter M, Uhling M, Sisic L, Bruckner T, Heininger A, Hohn A, Ott K, Schmidt T, Berger MM, Richter DC, Büchler M, Weigand MA, Busch CJ. Hochreiter M, et al. Among authors: hohn a. Infection. 2018 Oct;46(5):617-624. doi: 10.1007/s15010-018-1160-2. Epub 2018 Jun 5. Infection. 2018. PMID: 29869780
Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
Hagel S, Fiedler S, Hohn A, Brinkmann A, Frey OR, Hoyer H, Schlattmann P, Kiehntopf M, Roberts JA, Pletz MW; TARGET Study Group. Hagel S, et al. Among authors: hohn a. Trials. 2019 Jun 6;20(1):330. doi: 10.1186/s13063-019-3437-x. Trials. 2019. PMID: 31171029 Free PMC article.
[Cancer patients in operative intensive care medicine].
Annecke T, Hohn A, Böll B, Kochanek M. Annecke T, et al. Among authors: hohn a. Wien Klin Mag. 2018;21(2):68-77. doi: 10.1007/s00740-018-0218-1. Epub 2018 Feb 27. Wien Klin Mag. 2018. PMID: 32288864 Free PMC article. Review. German.
Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
Hagel S, Bach F, Brenner T, Bracht H, Brinkmann A, Annecke T, Hohn A, Weigand M, Michels G, Kluge S, Nierhaus A, Jarczak D, König C, Weismann D, Frey O, Witzke D, Müller C, Bauer M, Kiehntopf M, Neugebauer S, Lehmann T, Roberts JA, Pletz MW; TARGET Trial Investigators. Hagel S, et al. Among authors: hohn a. Intensive Care Med. 2022 Mar;48(3):311-321. doi: 10.1007/s00134-021-06609-6. Epub 2022 Feb 1. Intensive Care Med. 2022. PMID: 35106617 Free PMC article. Clinical Trial.
327 results